Elastofibroma Dorsi: Clinical Features, Surgical Outcomes, and Risk Factors

This study aims to retrospectively evaluate patients who underwent surgical treatment for elastofibroma dorsi, a rare benign tumor typically located in the subscapular region of the chest wall. The study will analyze demographic and clinical features, risk factors, diagnostic imaging methods, postoperative complications, and recurrence rates. By identifying potential predictors of complications and recurrence, the study hopes to contribute to the understanding and management of this silent and often incidental lesion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Elastofibroma Dorsi

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who underwent surgical treatment for elastofibroma dorsi
Histopathological confirmation of the diagnosis
Minimum of 1-month postoperative follow-up available
Age 18 years or older
Accessible medical and imaging records in hospital archives
Signed informed consent available in patient records (if applicable)

Exclusion criteria

Patients diagnosed with elastofibroma dorsi but not treated surgically
Cases without histopathological confirmation
Incomplete or insufficient medical and radiological records
Postoperative follow-up period less than 1 month
Patients younger than 18 years
Absence of documented informed consent (if applicable)

Treatment and study plan

Retrospective Medical Record Review

Other

Review of archived medical, surgical, and radiological records of patients diagnosed with elastofibroma dorsi and treated surgically. No active intervention was administered as part of the study.

Primary outcomes

Completion of Retrospective Data Collection Form

Time frame: Within 3 months after data collection begins

Completion of data collection from medical records of patients diagnosed with elastofibroma dorsi who underwent surgical treatment, including demographic features, clinical presentation, imaging modalities, surgical outcomes, postoperative complications, and recurrence.

Sponsors and collaborators

Lead sponsor

Ondokuz Mayıs University

Other

Registry information

Official study title

Clinical Characteristics of Elastofibroma Dorsi, Long-Term Outcomes After Surgical Resection, and Analysis of Risk Factors

Important dates

Study start: 2010
Primary completion: 2025
Study completion: 2025
First posted: Jun 8, 2025
Registry last updated: Jul 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.